The Health (Pricing and Supply of Medical Goods) Bill 2012 which was published on Friday, the 13th of July, will introduce a system of reference pricing and generic substitution for prescribed drugs and medicines. These reforms will promote price competition among suppliers and ensure that lower prices are paid for these medicines resulting in savings for taxpayers and patients.
It is not possible, at this juncture, to provide accurate figures regarding potential savings resulting from reference pricing, as these depend on various factors including prevailing prices, number of competitors, availability of substitute products, and market dynamics.